Trial intelligence / Profile preview

Rabies Vaccine (Human Diploid Cell), Freeze-dried: Essen vs Zagreb Regimens, Immunity Persistence and Booster Response in Healthy Subjects Aged 10–60 Years

CTR20263219Phase 4Active

Sponsor
Beijing Minhai Biological
Start
Sep 2026
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Human Diploid Cell Rabies Vaccine in rabies, sponsored by Beijing Minhai Biological. Started Sep 2026; status: active.

02

Drugs

Human Diploid Cell Rabies Vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on CTR20263219.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20263219.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call